After months of anticipation, the US Food and Drug Administration has finally granted traditional approval to lecemab, a drug that’s been shown to significantly slow the progression of Alzheimer’s.
For the full article, click here.
After months of anticipation, the US Food and Drug Administration has finally granted traditional approval to lecemab, a drug that’s been shown to significantly slow the progression of Alzheimer’s.
For the full article, click here.
0 Comments